At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody Imfinzi (durvalumab) with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as an ...

Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical ...

cystectomy in eight, and/or systemic therapy in seven. At last follow-up, 12 (48%) of the 25 patients remained metastasis free with an intact and non-irradiated bladder. The 2-year OS was 84.3% in ...

It involves removing both the bladder (called a cystectomy) and the prostate gland (prostatectomy) in men who have cancer that has spread to the muscles in the wall of the bladder. Often ...

Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...